Back

Cardiac magnetic resonance-derived left atrial global longitudinal strain identifies low-risk patients with hypertrophic cardiomyopathy

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Improving outcome prediction in hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Arnau Subira Ingla

University Hospital Vall d'Hebron, Barcelona (Spain)

7 More presentations in this session

Presentation thumbnail
Sudden cardiac death HCM risk scores in apical hypertrophic cardiomyopathy: an unmet need in clinical practice
Doctor A. Bello (Carnaxide, PT)
Abstract Slides Video
Presentation thumbnail
Bi-ventricular cardiovascular magnetic resonance strain phenotypes are predictive of cardiovascular outcomes in patients with asymptomatic hypertrophic cardiomyopathy
Ms S. Sajjad (Calgary, CA)
Abstract Slides Video
Presentation thumbnail
Hypertrophic cardiomyopathy increases the risks of bradyarrhythmia and pacemaker implantation: a nationwide cohort study
Doctor Y. Hsieh (Taichung, TW)
Abstract Slides Video
Presentation thumbnail
Longitudinal changes of left ventricular geometry and relationship with cardiac outcomes in patients with hypertrophic cardiomyopathy
Doctor T. Yoshitake (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
Assessment of syncope and long-term outcome in patients diagnosed with hypertrophic cardiomyopathy, a propensity score matching analysis
Doctor C. Fumagalli (Naples, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Improving outcome prediction in hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Left atrial strain predicts adverse events in hypertrophic cardiomyopathy: preliminary results from a CMR study
thumbnail
Congress Presentation
Additional value of left atrial and left ventricular strain in hypertrophic cardiomyopathy patients with low to intermediate risk of sudden cardiac death
thumbnail
Congress Presentation
Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources